Old Web
English
Sign In
Acemap
>
Paper
>
Zuranolone in Major Depressive Disorder: Interim Safety Results From a Phase 3, Open-Label, Longitudinal Study
Zuranolone in Major Depressive Disorder: Interim Safety Results From a Phase 3, Open-Label, Longitudinal Study
2021
Andrew J. Cutler
Scott Aaronson
Gregory Mattingly
Samuel T. Wilkinson
Robert Lasser
Indrani Nandy
Brian Werneburg
Jeffrey M. Jonas
Stephen J. Kanes
Timothy Y. Mariano
Keywords:
Longitudinal study
Psychiatry
Major depressive disorder
Phase (waves)
Medicine
Interim
open label
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]